🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My advance congratulations to Dr. Jesus San Miguel who will receive the European Hematology Association Lifetime Achievement Award Tomorrow at #EHA25 Dr. SanMiguel has made incredible contributions to the field. A close friend and mentor to me. I’m sorry to miss the ceremony.

Very proud of seeing Dr San-Miguel receiving this prestigious award at #EHA2025 . Well deserved by his scientific contributions and, I'd dare to say, by his close and extremely valuable supervision!

#EHA2025 lifetime achievement award to Dr. Jesús San Miguel. Congratulationsssssssss Clínica Universidad de Navarra Cima Universidad de Navarra @sehh_es PETHEMA CIMA LAB Diagnostics

👍Enhorabuena, muy merecido siempre, los #pacientes de #mieloma estamos con el Comunidad Española Pacientes con Mieloma Múltiple.

Amazing!!! #EHA2025 Clínica Universidad de Navarra CIMA LAB Diagnostics Cima Universidad de Navarra Universidad de Navarra #EHA2025 lifetime achievement award to Jesús San Miguel

#EHA2025 lifetime achievement award to Jesús San Miguel: "Happiness is not doing what you want but wanting what you do" JSM quotes the words of JP Sartre and shares his treasures with the audience: the big families he built at home, Hematología Salamanca Clínica Universidad de Navarra PETHEMA #mmsm

#EHA2025 survey by EMA in collaboration with Myeloma Society about attitudes of HCP and regulators towards MRD endpoint in myeloma #mmsm Varied opinions, but agreement that treatments with MRDneg increase of >20%, and toxicity increase from 40% to max 60%, were clinically useful

Our lab fantastic postdoc Juanjo Garcés will present today our study on CTC in multiple myeloma @mmsm. Several relevant findings by linking WGS, RNAseq and CTC. Great collaboration with Tomas Jelinek Ben Diamond, MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Memorial Sloan Kettering Cancer Center UNIVERSITY OF OSTRAVA ECON/SOC/ENVIRON HISTORY University of Miami Multiple Myeloma RF #mmsm

#EHA2025 had Carmen González Díaz-Cano presenting the phenotype and genetic landscape of clonotypic cells in myeloma and amyloidosis #mmsm These cells may be immature, carry some mutations but not drivers of progression. May explain some discordances between NGF/NGS MRD results. Cima Universidad de Navarra

#EHA2025 CTC session in myeloma and amyloidosis #mmsm CTCs are fighting for a sit on the table of routine staging of these patients. Congrats Ioannis Kostopoulos, Juanjo Garcés Luca Bertamini David Žihala Tomas Jelinek Mattia D’Agostino

CONGRESS | #EHA2025 | Luca Bertamini Erasmus MC presents results from a pooled analysis of prospective data, assessing the independent prognostic value of CTCs in newly diagnosed #MultipleMyeloma and plasma cell leukemia (N = 2446). Results support the assessment of CTC as a

📢SAVE THE DATE Próximo Webinar #PostASCO & #PostEHA 2025 de Sanofi España ¿Quieres conocer las novedades de ASCO y EHA en mieloma múltiple? ¡Conéctate! 🗓️26 de junio ⏰16:30–18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario

📢SAVE THE DATE Próximos #PostASCO Webinar #PostEHA 2025 Sanofi España Quer saber o que há de novo no mieloma múltiplo apresentado no ASCO e EHA? Conecte-se! 🗓️26 de junho ⏰16:30–18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde

📢SAVE THE DATE ¡El Webinar #PostASCO & #PostEHA 2025 de Sanofi España está aquí! Podrás conocer las novedades presentadas en ASCO y EHA de mieloma múltiple 🗓️26 de junio ⏰16:30 – 18:30 Registro👉 webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario

📢SAVE THE DATE O Webinar Sanofi España #PostASCO e #PostEHA 2025 está aqui! Poderá ver um resume dos resultados mais relevantes no mieloma múltiplo apresentados no ASCO e EHA 🗓️26 de junho ⏰16:30 – 18:30 Registo👉 webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde

Major Regulatory Milestone in MM: In response to an application by I2TEAMM and International Myeloma Foundation, the European Medicines Agency has officially endorsed MRD as an early endpoint in clinical trials for Myeloma. This marks a transformative step forward in drug development !! Vincent Rajkumar

📢 O webinar #PostASCO&#PostEHA 2025 da Sanofi España é esta quinta-feira dia 26! Atualize-se sobre o mieloma múltiplo revendo as coisas mais importantes apresentadas no ASCO e EHA. 🗓️26 de junho ⏰16:30 – 18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde

📢¡Este jueves 26 es el webinar #PostASCO & #PostEHA 2025 de Sanofi España! Ponte al día en mieloma múltiple revisando lo más importante visto en ASCO y EHA 🗓️26 de junio ⏰16:30 – 18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario

📢 O webinar Sanofi España #PostASCO e #PostEHA 2025 é esta quinta-feira dia 26! Descubra os últimos desenvolvimentos na abordagem completa do mieloma múltiplo 🗓️26 de junho ⏰16:30 – 18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde

📢 ¡El webinar #PostASCO & #PostEHA 2025 de Sanofi España es este jueves 26! Descubre las novedades en el abordaje integral del mieloma múltiple 🗓️26 de junio ⏰16:30 – 18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario